Follow-up of gastric cancer: a review
Tóm tắt
Although there is broad agreement in the staging, classification, and surgery for gastric cancer, there is no consensus regarding follow-up after gastrectomy. Follow-up varies from investigations on clinical suspicion of relapse to intensive investigations to detect recurrences early, assuming that this improves survival and quality of life. Advanced gastric cancers recur mainly by locoregional recurrence or distant metastasis. Local recurrences detected at endoscopy or on computed tomography (CT) are invariably incurable. For early gastric cancers, endoscopy can detect new primaries, but the incidence of these tumors is low, and many thousands of procedures are required to detect each operable case. CT is much better at detecting liver metastasis and, although these are usually multiple and unresectable, there are several reports of good survival following liver resection for isolated metastasis. Tumor markers have been used with some success to detect subclinical recurrences and could be used to target more invasive or expensive procedures. In chemotherapy, many newer agents are promising significantly improved survival, but again, the evidence for greater benefit when administered prior to the patient becoming symptomatic is lacking. Overall, it appears that follow-up policy is as much decided by the wealth and facilities of the institution as by any significant evidence base. Although the early detection of recurrent cancer is an emotive issue for both patients and surgeons, considering the amount of time and money invested in follow-up, and the lack of evidence of efficacy, a randomized controlled trial of intensive follow-up is required.
Tài liệu tham khảo
MT Hallissey WH Allum AJ Jewkes DJ Ellis JW Fielding (1990) ArticleTitleEarly detection of gastric cancer BMJ 301 513–5 Occurrence Handle2207416 Occurrence Handle1:STN:280:DyaK3M%2FgtlSnsg%3D%3D Occurrence Handle10.1136/bmj.301.6751.513
HM Sue-Ling D Johnston IG Martin MF Dixon MR Lansdown MJ McMahon et al. (1993) ArticleTitleGastric cancer: a curable disease in Britain BMJ 307 591–6 Occurrence Handle8401015 Occurrence Handle1:STN:280:DyaK2c%2FgsVagtQ%3D%3D
AG Renehan M Egger MP Saunders ST O'Dwyer (2002) ArticleTitleImpact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomized trials BMJ 324 813–6 Occurrence Handle11934773 Occurrence Handle10.1136/bmj.324.7341.813
Guidelines for the management of colorectal cancer. www.asgbi.org.uk 2001 cited; available from: www.asgbi.org.uk
CE Desch AB Benson Suffix3rd TJ Smith PJ Flynn C Krause CL Loprinzi et al. (1999) ArticleTitleRecommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology J Clin Oncol 17 1312–21 Occurrence Handle10561194 Occurrence Handle1:STN:280:DC%2BD3c%2FivF2hsQ%3D%3D
TJ Smith NE Davidson DV Schapira E Grunfeld HB Muss VG Vogel Suffix3rd et al. (1999) ArticleTitleAmerican Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines J Clin Oncol 17 1080–2 Occurrence Handle10071303 Occurrence Handle1:STN:280:DyaK1M7mvVylsw%3D%3D
InstitutionalAuthorNameClinical practice guidelines for the treatment of unresectable non-small-cell lung cancer (1997) ArticleTitleAdopted on May 16, 1997 by the American Society of Clinical Oncology J Clin Oncol 15 2996–3018
T Nakajima (2002) ArticleTitleGastric cancer treatment guidelines in Japan Gastric Cancer 5 1–5 Occurrence Handle12021853 Occurrence Handle10.1007/s101200200000
FE Johnson KS Virgo (1997) Cancer patient follow-up Mosby St Louis
F Roviello D Marrelli G de Manzoni P Morgagni A Di Leo L Saragoni et al. (2003) ArticleTitleProspective study of peritoneal recurrence after curative surgery for gastric cancer Br J Surg 90 1113–9 Occurrence Handle12945079 Occurrence Handle10.1002/bjs.4164 Occurrence Handle1:STN:280:DC%2BD3svgsFemsg%3D%3D
Y Maehara S Hasuda T Koga E Tokunaga Y Kakeji K Sugimachi (2000) ArticleTitlePostoperative outcome and sites of recurrence in patients following curative resection of gastric cancer Br J Surg 87 353–7 Occurrence Handle10718807 Occurrence Handle10.1046/j.1365-2168.2000.01358.x Occurrence Handle1:STN:280:DC%2BD3c7otlCjtg%3D%3D
N Shiraishi M Inomata N Osawa K Yasuda Y Adachi S Kitano (2000) ArticleTitleEarly and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses Cancer 89 255–61 Occurrence Handle10918153 Occurrence Handle10.1002/1097-0142(20000715)89:2<255::AID-CNCR8>3.0.CO;2-N Occurrence Handle1:STN:280:DC%2BD3czpt12qtA%3D%3D
S Ohno T Fujii S Ueda T Nakamoto S Kinugasa H Yoshimura et al. (2003) ArticleTitlePredictive factors and timing for liver recurrence after curative resection of gastric carcinoma Am J Surg 185 258–63 Occurrence Handle12620567 Occurrence Handle10.1016/S0002-9610(02)01377-6
RE Schwarz K Zagala-Nevarez (2002) ArticleTitleRecurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy Ann Surg Oncol 9 394–400 Occurrence Handle11986192 Occurrence Handle10.1245/aso.2002.9.4.394
N Arima K Adachi T Katsube K Amano S Ishihara M Watanabe et al. (1999) ArticleTitlePredictive factors for metachronous recurrence of early gastric cancer after endoscopic treatment (see comment) J Clin Gastroenterol 29 44–7 Occurrence Handle10405230 Occurrence Handle10.1097/00004836-199907000-00011 Occurrence Handle1:STN:280:DyaK1Mzjt1Wnsw%3D%3D
N Uemura T Mukai S Okamoto S Yamaguchi H Mashiba K Taniyama et al. (1997) ArticleTitleEffect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer Cancer Epidemiol Biomarkers Prev 6 639–42 Occurrence Handle9264278 Occurrence Handle1:STN:280:DyaK2svgslGhuw%3D%3D
LL Gunderson H Sosin (1982) ArticleTitleAdenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy Int J Radiat Oncol Biol Phy 8 1–11 Occurrence Handle1:STN:280:DyaL387ktFOmsw%3D%3D Occurrence Handle10.1016/0360-3016(82)90377-7
CH Yoo SH Noh DW Shin SH Choi JS Min (2000) ArticleTitleRecurrence following curative resection for gastric carcinoma Br J Surg 87 236–42 Occurrence Handle10671934 Occurrence Handle10.1046/j.1365-2168.2000.01360.x Occurrence Handle1:STN:280:DC%2BD3c7jslymsQ%3D%3D
H Katai K Maruyama M Sasako T Sano K Okajima T Kinoshita et al. (1994) ArticleTitleMode of recurrence after gastric cancer surgery Dig Surg 11 99–103 Occurrence Handle10.1159/000172232
T Sano M Sasako T Kinoshita K Maruyama (1993) ArticleTitleRecurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature (see comment) Cancer 72 3174–8 Occurrence Handle8242540 Occurrence Handle1:STN:280:DyaK2c%2FmtFOntw%3D%3D
HJ Lee YH Kim WH Kim KU Lee KJ Choe JP Kim et al. (2003) ArticleTitleClinicopathological analysis for recurrence of early gastric cancer Jpn J Clin Oncol 33 209–14 Occurrence Handle12865463 Occurrence Handle10.1093/jjco/hyg042
Y Kodera S Ito Y Yamamura Y Mochizuki M Fujiwara K Hibi et al. (2003) ArticleTitleFollow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit Ann Surg Oncol 10 898–902 Occurrence Handle14527908 Occurrence Handle10.1245/ASO.2003.12.009
JS Macdonald SR Smalley J Benedetti SA Hundahl NC Estes GN Stemmermann et al. (2001) ArticleTitleChemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction (see comment) New Engl J Med 345 725–30 Occurrence Handle11547741 Occurrence Handle10.1056/NEJMoa010187 Occurrence Handle1:STN:280:DC%2BD3Mvps1Cqug%3D%3D
SI Hironaka N Boku A Ohtsu F Nagashima Y Sano M Muto et al. (2000) ArticleTitleSequential methotrexate and 5-fluorouracil therapy for gastric cancer patients with bone metastasis Gastric Cancer 3 19–23 Occurrence Handle11984704 Occurrence Handle10.1007/PL00011684
AC Tersmette GJ Offerhaus KW Tersmette FM Giardiello GW Moore GN Tytgat et al. (1990) ArticleTitleMeta-analysis of the risk of gastric stump cancer: detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions Cancer Res 50 6486–9 Occurrence Handle2145061 Occurrence Handle1:STN:280:DyaK3M%2Fgtl2ruw%3D%3D
G Lundegardh HO Adami C Helmick M Zack O Meirik (1988) ArticleTitleStomach cancer after partial gastrectomy for benign ulcer disease N Engl J Med 319 195–200 Occurrence Handle3393171 Occurrence Handle1:STN:280:DyaL1c3ns1SnsA%3D%3D Occurrence Handle10.1056/NEJM198807283190402
S Kikuchi M Sato N Katada S Sakuramoto H Shimao A Kakita et al. (2003) ArticleTitleEfficacy of endoscopic surveillance of the upper gastrointestinal tract following distal gastrectomy for early gastric cancer Hepatogastroenterology 50 1704–7 Occurrence Handle14571822
S Thorban K Bottcher M Etter JD Roder R Busch JR Siewert (2000) ArticleTitlePrognostic factors in gastric stump carcinoma Ann Surg 231 188–94 Occurrence Handle10674609 Occurrence Handle10.1097/00000658-200002000-00006 Occurrence Handle1:STN:280:DC%2BD3c7jslSktg%3D%3D
SL Han YW Hua CH Wang SQ Ji J Zhuang (2003) ArticleTitleMetastatic pattern of lymph node and surgery for gastric stump cancer J Surg Oncol 82 241–6 Occurrence Handle12672008 Occurrence Handle10.1002/jso.10228
M Sasako K Maruyama T Kinoshita K Okabayashi (1991) ArticleTitleSurgical treatment of carcinoma of the gastric stump Br J Surg 78 822–4 Occurrence Handle1873711 Occurrence Handle1:STN:280:DyaK3MzjvV2qtw%3D%3D
CN Chen WJ Lee PH Lee KJ Chang KM Chen (1996) ArticleTitleClinicopathologic characteristics and prognosis of gastric stump cancer J Clin Gastroenterol 23 251–5 Occurrence Handle8957725 Occurrence Handle10.1097/00004836-199612000-00003 Occurrence Handle1:STN:280:DyaK2s7hs1KgtQ%3D%3D
F Tas N Faruk Aykan A Aydiner V Yasasever E Topuz (2001) ArticleTitleMeasurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer Am J Clin Oncol 24 148–9 Occurrence Handle11319289 Occurrence Handle10.1097/00000421-200104000-00010 Occurrence Handle1:STN:280:DC%2BD3M3jtVOrtQ%3D%3D
IR Lai WJ Lee MT Huang HH Lin (2002) ArticleTitleComparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence Hepatogastroenterology 49 1157–60 Occurrence Handle12143226
Y Takahashi T Takeuchi J Sakamoto T Touge M Mai H Ohkura et al. (2003) ArticleTitleThe usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study Gastric Cancer 6 142–5 Occurrence Handle14520526 Occurrence Handle10.1007/s10120-003-0240-9
Y Ikeda M Mori K Kajiyama T Kamakura Y Maehara Y Haraguchi et al. (1996) ArticleTitleIndicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of stage II and III gastric cancer Hepatogastroenterology 43 1281–7 Occurrence Handle8908563 Occurrence Handle1:STN:280:DyaK2s%2FmsFSisQ%3D%3D
HK Ha HH Kim HS Kim MH Lee KT Kim KS Shinn (1993) ArticleTitleLocal recurrence after surgery for gastric carcinoma: CT findings AJR Am J Roentgenol 161 975–7 Occurrence Handle8273639 Occurrence Handle1:STN:280:DyaK2c%2FpvFWqtw%3D%3D
T Sano S Yamamoto M Sasako (2002) ArticleTitleRandomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan Clinical Oncology Group study JCOG 0110-MF Jpn J Clin Oncol 32 363–4 Occurrence Handle12417603 Occurrence Handle10.1093/jjco/hyf085
K Kinkel Y Lu M Both RS Warren RF Thoeni (2002) ArticleTitleDetection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis Radiology 224 748–56 Occurrence Handle12202709
EK Insko MS Levine BA Birnbaum JE Jacobs (2003) ArticleTitleBenign and malignant lesions of the stomach: evaluation of CT criteria for differentiation Radiology 228 166–71 Occurrence Handle12759472
MA Meyers J McSweeney (1972) ArticleTitleSecondary neoplasms of the bowel Radiology 105 1–11 Occurrence Handle5066554 Occurrence Handle1:STN:280:DyaE383mvFylsw%3D%3D
H Jadvar R Tatlidil AA Garcia PS Conti (2003) ArticleTitleEvaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography (erratum appears in Clin Radiol 2003 Jul;58:570) Clin Radiol 58 215–21 Occurrence Handle12639527 Occurrence Handle10.1016/S0009-9260(02)00477-4 Occurrence Handle1:STN:280:DC%2BD3s7isFCntw%3D%3D
H Bohner T Zimmer W Hopfenmuller G Berger HJ Buhr (2000) ArticleTitleDetection and prognosis of recurrent gastric cancer — is routine follow-up after gastrectomy worthwhile? Hepatogastroenterology 47 1489–94 Occurrence Handle11100384 Occurrence Handle1:STN:280:DC%2BD3Mzgs12guw%3D%3D
T Inada Y Ogata J Andoh I Ozawa J Matsui S Hishinuma et al. (1994) ArticleTitleSignificance of para-aortic lymph node dissection in patients with advanced and recurrent gastric cancer Anticancer Res 14 677–82 Occurrence Handle8010726 Occurrence Handle1:STN:280:DyaK2c3otVWiuw%3D%3D
I Takeyoshi S Ohwada T Ogawa Y Kawashima T Ohya S Kawate et al. (2000) ArticleTitleThe resection of non-hepatic intraabdominal recurrence of gastric cancer Hepatogastroenterology 47 1479–81 Occurrence Handle11100381 Occurrence Handle1:STN:280:DC%2BD3Mzgs12gtA%3D%3D
MA Choti JV Sitzmann MF Tiburi W Sumetchotimetha R Rangsin RD Schulick et al. (2002) ArticleTitleTrends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 759–66 Occurrence Handle12035031 Occurrence Handle10.1097/00000658-200206000-00002
M Minagawa M Makuuchi G Torzilli T Takayama S Kawasaki T Kosuge et al. (2000) ArticleTitleExtension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results Ann Surg 231 487–99 Occurrence Handle10749608 Occurrence Handle10.1097/00000658-200004000-00006 Occurrence Handle1:STN:280:DC%2BD3c3htlaisA%3D%3D
T Ochiai M Sasako S Mizuno T Kinoshita T Takayama T Kosuge et al. (1994) ArticleTitleHepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors Br J Surg 81 1175–8 Occurrence Handle7953354 Occurrence Handle1:STN:280:DyaK2M%2FktFWntQ%3D%3D
M Miyazaki H Itoh K Nakagawa S Ambiru H Shimizu A Togawa et al. (1997) ArticleTitleHepatic resection of liver metastases from gastric carcinoma Am J Gastroenterol 92 490–3 Occurrence Handle9068476 Occurrence Handle1:STN:280:DyaK2s3itFCgsg%3D%3D
K Shirabe M Shimada T Matsumata H Higashi Y Yakeishi S Wakiyama et al. (2003) ArticleTitleAnalysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection Hepatogastroenterology 50 1560–3 Occurrence Handle14571786
Y Sakamoto S Ohyama J Yamamoto K Yamada M Seki K Ohta et al. (2003) ArticleTitleSurgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients Surgery 133 507–11 Occurrence Handle12773978 Occurrence Handle10.1067/msy.2003.147
J Zacherl M Zacherl C Scheuba R Steininger E Wenzl F Muhlbacher et al. (2002) ArticleTitleAnalysis of hepatic resection of metastasis originating from gastric adenocarcinoma J Gastrointest Surg 6 682–9 Occurrence Handle12399057 Occurrence Handle10.1016/S1091-255X(01)00075-0
A Saiura N Umekita S Inoue T Maeshiro S Miyamoto Y Matsui et al. (2002) ArticleTitleClinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer Hepatogastroenterology 49 1062–5 Occurrence Handle12143202
K Okano T Maeba K Ishimura Y Karasawa F Goda H Wakabayashi et al. (2002) ArticleTitleHepatic resection for metastatic tumors from gastric cancer Ann Surg 235 86–91 Occurrence Handle11753046 Occurrence Handle10.1097/00000658-200201000-00011
HH Hartgrink H Putter E Klein Kranenbarg JJ Bonenkamp CJ van de Velde (2002) ArticleTitleValue of palliative resection in gastric cancer Br J Surg 89 1438–43 Occurrence Handle12390389 Occurrence Handle10.1046/j.1365-2168.2002.02220.x Occurrence Handle1:STN:280:DC%2BD38njt1anug%3D%3D
T Haugstvedt A Viste GE Eide O Soreide (1989) ArticleTitleThe survival benefit of resection in patients with advanced stomach cancer: the Norwegian multicenter experience. Norwegian Stomach Cancer Trial World J Surg 13 617–21 Occurrence Handle2479177 Occurrence Handle10.1007/BF01658884 Occurrence Handle1:STN:280:DyaK3c%2FltFCjsg%3D%3D
JA Wils HO Klein DJ Wagener H Bleiberg H Reis F Korsten et al. (1991) ArticleTitleSequential high-dose methotrexate and fluorouracil combined with doxorubicin — a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group J Clin Oncol 9 827–31 Occurrence Handle2016625 Occurrence Handle1:STN:280:DyaK3M3gt1ajuw%3D%3D
AM Murad FF Santiago A Petroianu PR Rocha MA Rodrigues M Rausch (1993) ArticleTitleModified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer Cancer 72 37–41 Occurrence Handle8508427 Occurrence Handle1:STN:280:DyaK3s3osVGqtQ%3D%3D
U Vanhoefer P Rougier H Wilke MP Ducreux AJ Lacave E Van Cutsem et al. (2000) ArticleTitleFinal results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group (comment) J Clin Oncol 18 2648–57 Occurrence Handle10894863 Occurrence Handle1:CAS:528:DC%2BD3cXls12iurk%3D
T Moynihan R Hansen T Anderson E Quebbeman P Beatty R Ausman et al. (1988) ArticleTitleContinuous 5-fluorouracil infusion in advanced gastric carcinoma Am J Clin Oncol 11 461–4 Occurrence Handle3407626 Occurrence Handle1:STN:280:DyaL1czgslehtw%3D%3D
A Ohtsu Y Shimada K Shirao N Boku I Hyodo H Saito et al. (2003) ArticleTitleRandomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205) J Clin Oncol 21 54–9 Occurrence Handle12506170 Occurrence Handle10.1200/JCO.2003.04.130 Occurrence Handle1:CAS:528:DC%2BD2cXpsVWru7k%3D
HO Douglass SuffixJr PT Lavin A Goudsmit DJ Klaassen AR Paul (1984) ArticleTitleAn Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277) J Clin Oncol 2 1372–81 Occurrence Handle6439836
A Webb D Cunningham JH Scarffe P Harper A Norman JK Joffe et al. (1997) ArticleTitleRandomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer J Clin Oncol 15 261–7 Occurrence Handle8996151 Occurrence Handle1:CAS:528:DyaK2sXnsV2msA%3D%3D
JS Waters A Norman D Cunningham JH Scarffe A Webb P Harper et al. (1999) ArticleTitleLong-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial Br J Cancer 80 269–72 Occurrence Handle10390007 Occurrence Handle10.1038/sj.bjc.6690350 Occurrence Handle1:CAS:528:DyaK1MXjtFyksbo%3D
J Wils H Bleiberg O Dalesio G Blijham N Mulder A Planting et al. (1986) ArticleTitleAn EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer J Clin Oncol 4 1799–803 Occurrence Handle3783204 Occurrence Handle1:STN:280:DyaL2s%2FlvF2mug%3D%3D
C Stael von Holstein S Eriksson B Huldt E Hammar (1991) ArticleTitleEndoscopic screening during 17 years for gastric stump carcinoma. A prospective clinical trial Scand J Gastroenterol 26 1020–6 Occurrence Handle1947767 Occurrence Handle1:STN:280:DyaK38%2FlsVaitA%3D%3D
Cancer Statistics in Japan. (Cited; available from: http://www.ncc.go.jp/en/statistics/index.html)
A Berrington de Gonzalez S Darby (2004) ArticleTitleRisk of cancer from diagnostic X-rays: estimates for the United Kingdom and 14 other countries Lancet 363 345–51 Occurrence Handle15070562 Occurrence Handle10.1016/S0140-6736(04)15433-0